4-Hydroxynonenal differentially regulates adiponectin gene expression and secretion via activating PPARγ and accelerating ubiquitin-proteasome degradation

Mol Cell Endocrinol. 2012 Feb 26;349(2):222-31. doi: 10.1016/j.mce.2011.10.027. Epub 2011 Nov 10.

Abstract

Although well-established, the underlying mechanisms involved in obesity-related plasma adiponectin decline remain elusive. Oxidative stress is associated with obesity and insulin resistance and considered to contribute to the progression toward obesity-related metabolic disorders. In this study, we investigated the effects of 4-hydroxynonenal (4-HNE), the most abundant lipid peroxidation end product, on adiponectin production and its potential implication in obesity-related adiponectin decrease. Long-term high-fat diet feeding led to obesity in mouse, accompanied by decreased plasma adiponectin and increased adipose tissue 4-HNE content. Exposure of adipocytes to exogenous 4-HNE resulted in decreased adiponectin secretion in a dose-dependent manner, which was consistent with significantly decreased intracellular adiponectin protein abundance. In contrast, adiponectin gene expression was significantly elevated by 4-HNE treatment, which was concomitant with increased peroxisome proliferator-activated receptor gamma (PPAR-γ) gene expression and transactivity. The effect was abolished by T0070907, a PPAR-γ antagonist, suggesting that PPAR-γ activation plays a critical role in this process. To gain insight into mechanisms involved in adiponectin protein decrease, we examined the effects of 4-HNE on adiponectin protein degradation. Cycloheximide (CHX)-chase assay revealed that 4-HNE exposure accelerated adiponectin protein degradation, which was prevented by MG132, a potent proteasome inhibitor. Immunoprecipitation assay showed that 4-HNE exposure increased ubiquitinated adiponectin protein levels. These data altogether indicated that 4-HNE enhanced adiponectin protein degradation via ubiquitin-proteasome system. Finally, we demonstrated that supplementation of HF diet with betaine, an antioxidant and methyl donor, alleviated high-fat-induced adipose tissue 4-HNE increase and attenuated plasma adiponectin decline. Taken together, our findings suggest that the lipid peroxidation product 4-HNE can differentially regulates adiponectin gene expression and protein abundance and may play a mechanistic role in obesity-related plasma adiponectin decline.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • 3T3-L1 Cells
  • Adiponectin / blood*
  • Adiponectin / genetics
  • Adipose Tissue / cytology
  • Adipose Tissue / drug effects
  • Adipose Tissue / metabolism*
  • Aldehydes / metabolism*
  • Aldehydes / pharmacology
  • Animals
  • Benzamides / pharmacology
  • Diet, High-Fat
  • Dose-Response Relationship, Drug
  • Gene Expression
  • Insulin Resistance
  • Leupeptins / pharmacology
  • Lipid Peroxidation / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Obesity / blood*
  • Obesity / etiology
  • Oxidative Stress / drug effects
  • PPAR gamma / antagonists & inhibitors
  • PPAR gamma / blood*
  • PPAR gamma / genetics
  • Proteasome Endopeptidase Complex / metabolism*
  • Proteasome Inhibitors
  • Proteolysis
  • Pyridines / pharmacology
  • Ubiquitin / antagonists & inhibitors
  • Ubiquitin / metabolism
  • Up-Regulation

Substances

  • Adiponectin
  • Adipoq protein, mouse
  • Aldehydes
  • Benzamides
  • Leupeptins
  • PPAR gamma
  • Proteasome Inhibitors
  • Pyridines
  • T 0070907
  • Ubiquitin
  • Proteasome Endopeptidase Complex
  • 4-hydroxy-2-nonenal
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde